BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20436210)

  • 1. A review of substance abuse monitoring in a social services context: a primer for child protection workers.
    Moller M; Gareri J; Koren G
    Can J Clin Pharmacol; 2010; 17(1):e177-93. PubMed ID: 20436210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health.
    Koren G; Hutson J; Gareri J
    Clin Pharmacol Ther; 2008 Apr; 83(4):631-4. PubMed ID: 18288086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance abuse in pregnant women: making improved detection a good clinical outcome.
    Araojo R; McCune S; Feibus K
    Clin Pharmacol Ther; 2008 Apr; 83(4):520-2. PubMed ID: 18349872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs of abuse testing in meconium.
    Gareri J; Klein J; Koren G
    Clin Chim Acta; 2006 Apr; 366(1-2):101-11. PubMed ID: 16413011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alternative biological materials to detect prenatal exposure to drugs of abuse in the third trimester of pregnancy].
    García-Serra J; Ramis J; Simó S; Joya X; Pichini S; Vall O; García-Algar O
    An Pediatr (Barc); 2012 Nov; 77(5):323-8. PubMed ID: 22513392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Completing substance abuse treatment in child welfare: the role of co-occurring problems and primary drug of choice.
    Choi S; Ryan JP
    Child Maltreat; 2006 Nov; 11(4):313-25. PubMed ID: 17043316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of prenatal drug exposure in the pregnant women and her newborn infant.
    Ostrea EM; Welch RA
    Clin Perinatol; 1991 Sep; 18(3):629-45. PubMed ID: 1934859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.
    Grella CE; Hser YI; Huang YC
    Child Abuse Negl; 2006 Jan; 30(1):55-73. PubMed ID: 16406024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection.
    Concheiro M; González-Colmenero E; Lendoiro E; Concheiro-Guisán A; de Castro A; Cruz-Landeira A; López-Rivadulla M
    Ther Drug Monit; 2013 Aug; 35(4):502-9. PubMed ID: 23851907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.
    Ostrea EM; Knapp DK; Tannenbaum L; Ostrea AR; Romero A; Salari V; Ager J
    J Pediatr; 2001 Mar; 138(3):344-8. PubMed ID: 11241040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance abuse interventions for parents involved in the child welfare system: evidence and implications.
    Osterling KL; Austin MJ
    J Evid Based Soc Work; 2008; 5(1-2):157-89. PubMed ID: 19064448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine drug testing for social service agencies. A Canadian experience.
    Fraser AD
    Clin Lab Med; 1998 Dec; 18(4):705-11. PubMed ID: 9891609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug testing in the neonate.
    Cotten SW
    Clin Lab Med; 2012 Sep; 32(3):449-66. PubMed ID: 22939302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hair analysis for drug detection.
    Kintz P; Villain M; Cirimele V
    Ther Drug Monit; 2006 Jun; 28(3):442-6. PubMed ID: 16778731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews.
    Bibb KW; Stewart DL; Walker JR; Cook VD; Wagener RE
    J Perinatol; 1995; 15(3):199-202. PubMed ID: 7666268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hair testing is taking root.
    Cooper GA
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):516-30. PubMed ID: 21868416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal and neonatal hair and breast milk in the assessment of perinatal exposure to drugs of abuse.
    Joya X; Pacifici R; Salat-Batlle J; García-Algar O; Pichini S
    Bioanalysis; 2015; 7(10):1273-97. PubMed ID: 26045006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants.
    Boumba VA; Ziavrou KS; Vougiouklakis T
    Int J Toxicol; 2006; 25(3):143-63. PubMed ID: 16717031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of hair analysis in postmortem toxicology.
    Kintz P
    Forensic Sci Int; 2004 Jun; 142(2-3):127-34. PubMed ID: 15172076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone and illegal drugs in hair from children with parents in maintenance treatment or suspected for drug abuse in a German community.
    Pragst F; Broecker S; Hastedt M; Herre S; Andresen-Streichert H; Sachs H; Tsokos M
    Ther Drug Monit; 2013 Dec; 35(6):737-52. PubMed ID: 24263638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.